Alaunos Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
TCRT on Nasdaq
Location
2617 Bissonnet St, Suite 225, Houston, TX

There are no Buy or Sell transactions made by insiders since 9/14/2023

Alaunos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kevin S. Sr. Boyle Chief Executive Officer, Director $112K Sep 1, 2023
Raffaele Baffa Chief Medical Officer $39.4K May 17, 2021
Eleanor De Groot EVP, Operations $33.3K Mar 30, 2022
James Huang Director $26.4K Jun 6, 2023
Heidi Hagen Director $20.5K Sep 2, 2021
Mary Thistle Director $6.31K Jun 6, 2023
Christopher Bowden Director $6.2K Jun 22, 2022
Drew Deniger Vice President, Research and Development $2.11K Mar 15, 2023
Abhishek K. Srivastava Vice President, Technical Operations $168 Mar 15, 2023
Robert Hofmeister Director Jun 6, 2024
Holger Weis Director Jun 6, 2024
Jaime Vieser Director Jun 6, 2024
Michael Wong Vice President, Finance Mar 15, 2023
Melinda Lackey Legal & Administration Aug 14, 2024
Robert W. Postma Director Jun 6, 2024
Dale Curtis Hogue Jr. Interim CEO, Director Jan 20, 2024
Ferdinand Groenewald VP, Finance Aug 14, 2024

Recent Insider Transactions by Companies or Individuals for Alaunos Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.